Osijek

Croatia

84 total trials 37 recruiting

Filter these 84 trials by phase, condition, sponsor and more.

Open in Search →

Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis Ended

2023-508679-34-00 4 2024-07-30 Ulcerative Colitis
A research study comparing how well different doses of the medicine NNC0487-0111 lower blood sugar in people with type 2 diabetes Ended

2023-509412-28-00 4 2024-07-26 Type 2 Diabetes
Functional Constipation: A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Le … Ended

2022-501947-34-00 4 2023-12-05 Functional Constipation (FC)
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight … Ended

2022-502678-18-00 5 2023-11-07 Type 2 diabetes
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 5 2023-06-08 Moderately to severely active ulcerative colitis
Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO) Ended

2022-501586-50-00 5 2023-05-15 Atopic Dermatitis
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 5 2022-12-21 geographic atrophy
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 5 2021-08-27 Neovascular Age-related Macular Degeneration (wet AMD)
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan … Ended

2024-513569-38-00 10 2021-07-09 Crohn's Disease
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy Ended

2023-510174-13-00 5 2021-06-17 Chronic Obstructive Pulmonary Disease (COPD)
Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality Ended

2022-502187-20-00 5 2019-04-11 Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected eith
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio … Ended

2023-509206-29-00 5 Neovascular age-related macular degeneration (nAMD)

Showing 73–84 of 84 trials